Pages that link to "Q34123956"
Jump to navigation
Jump to search
The following pages link to Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay (Q34123956):
Displaying 45 items.
- Dengue Virus Antibodies Enhance Zika Virus Infection (Q24737469) (← links)
- Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection (Q26252507) (← links)
- MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus (Q26700001) (← links)
- Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein (Q27468788) (← links)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity (Q27654848) (← links)
- Dengue virus antibodies enhance Zika virus infection (Q28353949) (← links)
- Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein (Q33784307) (← links)
- Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop (Q34306877) (← links)
- The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein (Q34386384) (← links)
- C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins (Q34540907) (← links)
- Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry (Q34580259) (← links)
- Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination (Q34863111) (← links)
- Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. (Q34607919) (← links)
- Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody (Q34976206) (← links)
- Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases (Q34999885) (← links)
- Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA (Q35081258) (← links)
- Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera (Q35294150) (← links)
- A Highly Sensitive Diagnostic System for Detecting Dengue Viruses Using the Interaction between a Sulfated Sugar Chain and a Virion (Q35641137) (← links)
- Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies (Q35758626) (← links)
- Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM (Q35781863) (← links)
- Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine (Q36029040) (← links)
- Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus (Q36286276) (← links)
- Insight into SNPs and epitopes of E protein of newly emerged genotype-I isolates of JEV from Midnapur, West Bengal, India. (Q36298697) (← links)
- A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection (Q37012203) (← links)
- High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection (Q37336440) (← links)
- Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool (Q37363501) (← links)
- Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice (Q38156841) (← links)
- Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus (Q38158247) (← links)
- Feasibility Study of an Optical Caustic Plasmonic Light Scattering Sensor for Human Serum Anti-Dengue Protein E Antibody Detection. (Q38620254) (← links)
- Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement (Q38697863) (← links)
- Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III. (Q38765315) (← links)
- Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1. (Q38899058) (← links)
- Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1. (Q38942473) (← links)
- Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus (Q39358459) (← links)
- Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination (Q39470840) (← links)
- Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development (Q39535403) (← links)
- Development of Peptide Vaccines in Dengue. (Q40038715) (← links)
- A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. (Q51336614) (← links)
- Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases. (Q54241842) (← links)
- Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine (Q59353226) (← links)
- Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library (Q61798447) (← links)
- Alanine Substitution Inactivates Cross-Reacting Epitopes in Dengue Virus Recombinant Envelope Proteins (Q89761345) (← links)
- Seeking Flavivirus Cross-Protective Immunity (Q90733120) (← links)
- Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice (Q91650081) (← links)
- Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections (Q97539391) (← links)